Tumour mutation burden

1 paper

In silico1

Latest

2 in 12 months

medRxiv11 Aug

Classical driver mutations are not associated with metachronous lesion risk in patients undergoing post-polypectomy surveillance following removal of conventional adenomas in a bowel screening setting

Preprint: cohort study of 723 peopleBiomarkers

Journal of the College of Physicians and Surgeons--Pakistan6 Dec

Development of a Cellular Senescence-Related Risk Model as a Prognostic Biomarker and Immunotherapy Response in Lung Squamous Cell Carcinoma

Computational studyBiomarkers